A holistic view of innovation incentives and pharmaceutical policy reform
{{output}}
The Inflation Reduction Act is set to transform how Medicare pays for prescription drugs, most notably by enabling Medicare to negotiate for the prices of certain high-cost medications. The pharmaceutical industry argues it will drastically reduce innovation, ... ...
